Sunshine Biopharma Inc expected to post a loss of 6 cents a share - Earnings Preview

Sunshine Biopharma

03/11/2023 11:34

* Sunshine Biopharma Inc  SBFM.OQ   SBFM.O  is expected
to report
results
    * The Pointe-claire Quebec-based  company is expected to
report
revenue of $6 million, according to the estimate from one
analyst, based on LSEG data.  
    * ​Refinitiv's mean analyst estimate for Sunshine Biopharma
Inc is
for a loss of 6 cents per share. 
    * The one available analyst rating on the shares is "buy".  
    * The average consensus recommendation for
the pharmaceuticals
peer group is also "Buy".​
    * Wall Street's median 12-month price target for Sunshine
Biopharma Inc is $3​, above​ its last closing price of $0.27.
​​​

This summary was machine generated November 3 at 11:33 GMT.  All
figures in US dollars  unless otherwise stated